Snowball logo
logo
ARQT_logo

Arcutis Biotherapeutics, Inc

ARQT β€’ NASDAQ
$23.885+$0.505Β  (2.16%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
-3.68659.61196.5376.1464
COGS
0.7630.7544.98719.1336.741.1
Gross Profit
(0.763)2.93254.62177.4339.4422.9
Operating Expenses & Income
Operating Income
(206.5)(301.6)(241.1)(128.4)(12.23)34.25
Total Operating Expenses
206.5304.6295.7305.8351.6388.6
R&D Expenses
145.6182.4110.676.4277.0591.04
Selling General & Admin Expenses
60.97122.1173.5222.5274.6297.6
Earnings from Continuing Operations
Interest Expense
(0.454)(15.65)(29.71)(27.17)(12.08)(13.85)
Interest Income
--12.5216.138.8974.554
Income Tax Expense
(0.454)9.8313.1130.6471.1710.779
Net Income
Net Income
(205.9)(311.5)(262.1)(140)(16.14)28.52
Supplemental
EBIT
(206.5)(295.8)(229.3)(112.2)(2.887)41.18
EBITDA
(206.1)(294.6)(227.4)(109.6)2.4844.13
In millions of USD, except % and values per 1 share